Two Sequential Clinical Isolates of <i>Candida glabrata</i> with Multidrug-Resistance to Posaconazole and Echinocandins
<i>Candida glabrata</i> is one of the most prevalent causative pathogens of invasive candidiasis, and multidrug-resistant strains are emerging. We identified two clinical isolates of <i>C. glabrata</i>, BMU10720 and BMU10722 sequentially isolated from one patient with multidr...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_c995c4f8e7544ce1b04b65a142bc4c20 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Qiqi Wang |e author |
700 | 1 | 0 | |a Yun Li |e author |
700 | 1 | 0 | |a Xuan Cai |e author |
700 | 1 | 0 | |a Ruoyu Li |e author |
700 | 1 | 0 | |a Bo Zheng |e author |
700 | 1 | 0 | |a Ence Yang |e author |
700 | 1 | 0 | |a Tianyu Liang |e author |
700 | 1 | 0 | |a Xinyu Yang |e author |
700 | 1 | 0 | |a Zhe Wan |e author |
700 | 1 | 0 | |a Wei Liu |e author |
245 | 0 | 0 | |a Two Sequential Clinical Isolates of <i>Candida glabrata</i> with Multidrug-Resistance to Posaconazole and Echinocandins |
260 | |b MDPI AG, |c 2021-10-01T00:00:00Z. | ||
500 | |a 10.3390/antibiotics10101217 | ||
500 | |a 2079-6382 | ||
520 | |a <i>Candida glabrata</i> is one of the most prevalent causative pathogens of invasive candidiasis, and multidrug-resistant strains are emerging. We identified two clinical isolates of <i>C. glabrata</i>, BMU10720 and BMU10722 sequentially isolated from one patient with multidrug-resistance to posaconazole (POS), caspofungin (CAS), micafungin (MCF), and anidulafungin (ANF). Overexpression of <i>ERG11</i> in BMU10720 and <i>CDR1</i> in BMU10722 were detected at basal level. When exposed to POS, <i>CDR1</i> was significantly up-regulated in both isolates compared with susceptible reference strain, while <i>ERG11</i> was up-regulated considerably only in BMU10720. <i>PDR1</i> sequencing revealed that both isolates harbored P76S, P143T, and D243N substitutions, while <i>ERG11</i> was intact. Cdr1 inhibitor FK520 reversed POS-resistance by down-regulating <i>ERG11</i> expression. <i>FKS</i> sequencing revealed that both isolates harbored S663P substitution in <i>FKS2</i>, and four single nucleotide polymorphisms (SNPs) existed in <i>FKS2</i> genes between BMU10720 and BMU10722, while <i>FKS1</i> was intact. Both <i>FKS1</i> and <i>FKS2</i> were up-regulated by CAS in BMU10720 and BMU10722. FK520 down-regulated <i>FKS2</i> expression induced by CAS through inhibiting calcineurin, resulting in synergic effect with echinocandins as well as Congo Red and Calcofluor White, two cell wall-perturbing agents. In conclusion, the multidrug-resistance of <i>C. glabrata</i> isolates in our study was conferred by different mechanisms. <i>CDR1</i> and <i>ERG11</i> overexpression in one isolate and only <i>CDR1</i> overexpression in the other isolate may mediate POS-resistance. S663P mutation in <i>FKS2</i> and up-regulation of <i>FKS2</i> may contribute to echinocandin-resistance in both isolates. | ||
546 | |a EN | ||
690 | |a <i>Candida glabrata</i> | ||
690 | |a multidrug-resistance | ||
690 | |a echinocandins | ||
690 | |a triazoles | ||
690 | |a posaconazole | ||
690 | |a FK520 | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Antibiotics, Vol 10, Iss 10, p 1217 (2021) | |
787 | 0 | |n https://www.mdpi.com/2079-6382/10/10/1217 | |
787 | 0 | |n https://doaj.org/toc/2079-6382 | |
856 | 4 | 1 | |u https://doaj.org/article/c995c4f8e7544ce1b04b65a142bc4c20 |z Connect to this object online. |